Global Genetic Virus Vector Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 220567
  • calendar_today Published On: Jun, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Genetic Virus Vector market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Genetic Virus Vector size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Genetic Virus Vector market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Genetic Virus Vector market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Retroviral Vectors

Adenoviral Vectors

Adeno-Associated Viral Vectors

Other

Market segment by Application, can be divided into

Gene Therapy

Vaccinology

Market segment by players, this report covers

FUJIFILM Diosynth Biotechnologies U.S.A.

Sanofi

Lonza

Merck KGaA

GENERAL ELECTRIC COMPANY

Oxford BioMedica

Spark Therapeutics, Inc.

uniQure N.V.

FinVector Vision Therapies

Brammer Bio

Cell and Gene Therapy Catapult

Cobra Biologics

REGENXBIO Inc.

Kaneka Eurogentec S.A.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Genetic Virus Vector product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Genetic Virus Vector, with revenue, gross margin and global market share of Genetic Virus Vector from 2019 to 2021.

Chapter 3, the Genetic Virus Vector competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Genetic Virus Vector market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Genetic Virus Vector research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Genetic Virus Vector

1.2 Classification of Genetic Virus Vector by Type

1.2.1 Overview: Global Genetic Virus Vector Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Genetic Virus Vector Revenue Market Share by Type in 2020

1.2.3 Retroviral Vectors

1.2.4 Adenoviral Vectors

1.2.5 Adeno-Associated Viral Vectors

1.2.6 Other

1.3 Global Genetic Virus Vector Market by Application

1.3.1 Overview: Global Genetic Virus Vector Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Gene Therapy

1.3.3 Vaccinology

1.4 Global Genetic Virus Vector Market Size & Forecast

1.5 Global Genetic Virus Vector Market Size and Forecast by Region

1.5.1 Global Genetic Virus Vector Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Genetic Virus Vector Market Size by Region, (2016-2021)

1.5.3 North America Genetic Virus Vector Market Size and Prospect (2016-2026)

1.5.4 Europe Genetic Virus Vector Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Genetic Virus Vector Market Size and Prospect (2016-2026)

1.5.6 South America Genetic Virus Vector Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Genetic Virus Vector Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Genetic Virus Vector Market Drivers

1.6.2 Genetic Virus Vector Market Restraints

1.6.3 Genetic Virus Vector Trends Analysis

2 Company Profiles

2.1 FUJIFILM Diosynth Biotechnologies U.S.A.

2.1.1 FUJIFILM Diosynth Biotechnologies U.S.A. Details

2.1.2 FUJIFILM Diosynth Biotechnologies U.S.A. Major Business

2.1.3 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product and Solutions

2.1.4 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 FUJIFILM Diosynth Biotechnologies U.S.A. Recent Developments and Future Plans

2.2 Sanofi

2.2.1 Sanofi Details

2.2.2 Sanofi Major Business

2.2.3 Sanofi Genetic Virus Vector Product and Solutions

2.2.4 Sanofi Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Sanofi Recent Developments and Future Plans

2.3 Lonza

2.3.1 Lonza Details

2.3.2 Lonza Major Business

2.3.3 Lonza Genetic Virus Vector Product and Solutions

2.3.4 Lonza Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Lonza Recent Developments and Future Plans

2.4 Merck KGaA

2.4.1 Merck KGaA Details

2.4.2 Merck KGaA Major Business

2.4.3 Merck KGaA Genetic Virus Vector Product and Solutions

2.4.4 Merck KGaA Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Merck KGaA Recent Developments and Future Plans

2.5 GENERAL ELECTRIC COMPANY

2.5.1 GENERAL ELECTRIC COMPANY Details

2.5.2 GENERAL ELECTRIC COMPANY Major Business

2.5.3 GENERAL ELECTRIC COMPANY Genetic Virus Vector Product and Solutions

2.5.4 GENERAL ELECTRIC COMPANY Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 GENERAL ELECTRIC COMPANY Recent Developments and Future Plans

2.6 Oxford BioMedica

2.6.1 Oxford BioMedica Details

2.6.2 Oxford BioMedica Major Business

2.6.3 Oxford BioMedica Genetic Virus Vector Product and Solutions

2.6.4 Oxford BioMedica Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Oxford BioMedica Recent Developments and Future Plans

2.7 Spark Therapeutics, Inc.

2.7.1 Spark Therapeutics, Inc. Details

2.7.2 Spark Therapeutics, Inc. Major Business

2.7.3 Spark Therapeutics, Inc. Genetic Virus Vector Product and Solutions

2.7.4 Spark Therapeutics, Inc. Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Spark Therapeutics, Inc. Recent Developments and Future Plans

2.8 uniQure N.V.

2.8.1 uniQure N.V. Details

2.8.2 uniQure N.V. Major Business

2.8.3 uniQure N.V. Genetic Virus Vector Product and Solutions

2.8.4 uniQure N.V. Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 uniQure N.V. Recent Developments and Future Plans

2.9 FinVector Vision Therapies

2.9.1 FinVector Vision Therapies Details

2.9.2 FinVector Vision Therapies Major Business

2.9.3 FinVector Vision Therapies Genetic Virus Vector Product and Solutions

2.9.4 FinVector Vision Therapies Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 FinVector Vision Therapies Recent Developments and Future Plans

2.10 Brammer Bio

2.10.1 Brammer Bio Details

2.10.2 Brammer Bio Major Business

2.10.3 Brammer Bio Genetic Virus Vector Product and Solutions

2.10.4 Brammer Bio Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Brammer Bio Recent Developments and Future Plans

2.11 Cell and Gene Therapy Catapult

2.11.1 Cell and Gene Therapy Catapult Details

2.11.2 Cell and Gene Therapy Catapult Major Business

2.11.3 Cell and Gene Therapy Catapult Genetic Virus Vector Product and Solutions

2.11.4 Cell and Gene Therapy Catapult Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Cell and Gene Therapy Catapult Recent Developments and Future Plans

2.12 Cobra Biologics

2.12.1 Cobra Biologics Details

2.12.2 Cobra Biologics Major Business

2.12.3 Cobra Biologics Genetic Virus Vector Product and Solutions

2.12.4 Cobra Biologics Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Cobra Biologics Recent Developments and Future Plans

2.13 REGENXBIO Inc.

2.13.1 REGENXBIO Inc. Details

2.13.2 REGENXBIO Inc. Major Business

2.13.3 REGENXBIO Inc. Genetic Virus Vector Product and Solutions

2.13.4 REGENXBIO Inc. Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 REGENXBIO Inc. Recent Developments and Future Plans

2.14 Kaneka Eurogentec S.A.

2.14.1 Kaneka Eurogentec S.A. Details

2.14.2 Kaneka Eurogentec S.A. Major Business

2.14.3 Kaneka Eurogentec S.A. Genetic Virus Vector Product and Solutions

2.14.4 Kaneka Eurogentec S.A. Genetic Virus Vector Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Kaneka Eurogentec S.A. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Genetic Virus Vector Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Genetic Virus Vector Players Market Share

3.2.2 Top 10 Genetic Virus Vector Players Market Share

3.2.3 Market Competition Trend

3.3 Genetic Virus Vector Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Genetic Virus Vector Revenue and Market Share by Type (2016-2021)

4.2 Global Genetic Virus Vector Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Genetic Virus Vector Revenue Market Share by Application (2016-2021)

5.2 Genetic Virus Vector Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Genetic Virus Vector Revenue by Type (2016-2026)

6.2 North America Genetic Virus Vector Revenue by Application (2016-2026)

6.3 North America Genetic Virus Vector Market Size by Country

6.3.1 North America Genetic Virus Vector Revenue by Country (2016-2026)

6.3.2 United States Genetic Virus Vector Market Size and Forecast (2016-2026)

6.3.3 Canada Genetic Virus Vector Market Size and Forecast (2016-2026)

6.3.4 Mexico Genetic Virus Vector Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Genetic Virus Vector Revenue by Type (2016-2026)

7.2 Europe Genetic Virus Vector Revenue by Application (2016-2026)

7.3 Europe Genetic Virus Vector Market Size by Country

7.3.1 Europe Genetic Virus Vector Revenue by Country (2016-2026)

7.3.2 Germany Genetic Virus Vector Market Size and Forecast (2016-2026)

7.3.3 France Genetic Virus Vector Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Genetic Virus Vector Market Size and Forecast (2016-2026)

7.3.5 Russia Genetic Virus Vector Market Size and Forecast (2016-2026)

7.3.6 Italy Genetic Virus Vector Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Genetic Virus Vector Revenue by Type (2016-2026)

8.2 Asia-Pacific Genetic Virus Vector Revenue by Application (2016-2026)

8.3 Asia-Pacific Genetic Virus Vector Market Size by Region

8.3.1 Asia-Pacific Genetic Virus Vector Revenue by Region (2016-2026)

8.3.2 China Genetic Virus Vector Market Size and Forecast (2016-2026)

8.3.3 Japan Genetic Virus Vector Market Size and Forecast (2016-2026)

8.3.4 South Korea Genetic Virus Vector Market Size and Forecast (2016-2026)

8.3.5 India Genetic Virus Vector Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Genetic Virus Vector Market Size and Forecast (2016-2026)

8.3.7 Australia Genetic Virus Vector Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Genetic Virus Vector Revenue by Type (2016-2026)

9.2 South America Genetic Virus Vector Revenue by Application (2016-2026)

9.3 South America Genetic Virus Vector Market Size by Country

9.3.1 South America Genetic Virus Vector Revenue by Country (2016-2026)

9.3.2 Brazil Genetic Virus Vector Market Size and Forecast (2016-2026)

9.3.3 Argentina Genetic Virus Vector Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Genetic Virus Vector Revenue by Type (2016-2026)

10.2 Middle East & Africa Genetic Virus Vector Revenue by Application (2016-2026)

10.3 Middle East & Africa Genetic Virus Vector Market Size by Country

10.3.1 Middle East & Africa Genetic Virus Vector Revenue by Country (2016-2026)

10.3.2 Turkey Genetic Virus Vector Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Genetic Virus Vector Market Size and Forecast (2016-2026)

10.3.4 UAE Genetic Virus Vector Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Genetic Virus Vector Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Genetic Virus Vector Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Genetic Virus Vector Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Genetic Virus Vector Revenue (USD Million) by Region (2016-2021)

Table 5. Global Genetic Virus Vector Revenue Market Share by Region (2021-2026)

Table 6. FUJIFILM Diosynth Biotechnologies U.S.A. Corporate Information, Head Office, and Major Competitors

Table 7. FUJIFILM Diosynth Biotechnologies U.S.A. Major Business

Table 8. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Product and Solutions

Table 9. FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Sanofi Corporate Information, Head Office, and Major Competitors

Table 11. Sanofi Major Business

Table 12. Sanofi Genetic Virus Vector Product and Solutions

Table 13. Sanofi Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Lonza Corporate Information, Head Office, and Major Competitors

Table 15. Lonza Major Business

Table 16. Lonza Genetic Virus Vector Product and Solutions

Table 17. Lonza Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 19. Merck KGaA Major Business

Table 20. Merck KGaA Genetic Virus Vector Product and Solutions

Table 21. Merck KGaA Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. GENERAL ELECTRIC COMPANY Corporate Information, Head Office, and Major Competitors

Table 23. GENERAL ELECTRIC COMPANY Major Business

Table 24. GENERAL ELECTRIC COMPANY Genetic Virus Vector Product and Solutions

Table 25. GENERAL ELECTRIC COMPANY Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Oxford BioMedica Corporate Information, Head Office, and Major Competitors

Table 27. Oxford BioMedica Major Business

Table 28. Oxford BioMedica Genetic Virus Vector Product and Solutions

Table 29. Oxford BioMedica Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Spark Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors

Table 31. Spark Therapeutics, Inc. Major Business

Table 32. Spark Therapeutics, Inc. Genetic Virus Vector Product and Solutions

Table 33. Spark Therapeutics, Inc. Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. uniQure N.V. Corporate Information, Head Office, and Major Competitors

Table 35. uniQure N.V. Major Business

Table 36. uniQure N.V. Genetic Virus Vector Product and Solutions

Table 37. uniQure N.V. Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. FinVector Vision Therapies Corporate Information, Head Office, and Major Competitors

Table 39. FinVector Vision Therapies Major Business

Table 40. FinVector Vision Therapies Genetic Virus Vector Product and Solutions

Table 41. FinVector Vision Therapies Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Brammer Bio Corporate Information, Head Office, and Major Competitors

Table 43. Brammer Bio Major Business

Table 44. Brammer Bio Genetic Virus Vector Product and Solutions

Table 45. Brammer Bio Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Cell and Gene Therapy Catapult Corporate Information, Head Office, and Major Competitors

Table 47. Cell and Gene Therapy Catapult Major Business

Table 48. Cell and Gene Therapy Catapult Genetic Virus Vector Product and Solutions

Table 49. Cell and Gene Therapy Catapult Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Cobra Biologics Corporate Information, Head Office, and Major Competitors

Table 51. Cobra Biologics Major Business

Table 52. Cobra Biologics Genetic Virus Vector Product and Solutions

Table 53. Cobra Biologics Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. REGENXBIO Inc. Corporate Information, Head Office, and Major Competitors

Table 55. REGENXBIO Inc. Major Business

Table 56. REGENXBIO Inc. Genetic Virus Vector Product and Solutions

Table 57. REGENXBIO Inc. Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Kaneka Eurogentec S.A. Corporate Information, Head Office, and Major Competitors

Table 59. Kaneka Eurogentec S.A. Major Business

Table 60. Kaneka Eurogentec S.A. Genetic Virus Vector Product and Solutions

Table 61. Kaneka Eurogentec S.A. Genetic Virus Vector Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Global Genetic Virus Vector Revenue (USD Million) by Players (2019-2021)

Table 63. Global Genetic Virus Vector Revenue Share by Players (2019-2021)

Table 64. Breakdown of Genetic Virus Vector by Company Type (Tier 1, Tier 2 and Tier 3)

Table 65. Genetic Virus Vector Players Head Office, Products and Services Provided

Table 66. Genetic Virus Vector Mergers & Acquisitions in the Past Five Years

Table 67. Genetic Virus Vector New Entrants and Expansion Plans

Table 68. Global Genetic Virus Vector Revenue (USD Million) by Type (2016-2021)

Table 69. Global Genetic Virus Vector Revenue Share by Type (2016-2021)

Table 70. Global Genetic Virus Vector Revenue Forecast by Type (2021-2026)

Table 71. Global Genetic Virus Vector Revenue by Application (2016-2021)

Table 72. Global Genetic Virus Vector Revenue Forecast by Application (2021-2026)

Table 73. North America Genetic Virus Vector Revenue by Type (2016-2021) & (USD Million)

Table 74. North America Genetic Virus Vector Revenue by Type (2021-2026) & (USD Million)

Table 75. North America Genetic Virus Vector Revenue by Application (2016-2021) & (USD Million)

Table 76. North America Genetic Virus Vector Revenue by Application (2021-2026) & (USD Million)

Table 77. North America Genetic Virus Vector Revenue by Country (2016-2021) & (USD Million)

Table 78. North America Genetic Virus Vector Revenue by Country (2021-2026) & (USD Million)

Table 79. Europe Genetic Virus Vector Revenue by Type (2016-2021) & (USD Million)

Table 80. Europe Genetic Virus Vector Revenue by Type (2021-2026) & (USD Million)

Table 81. Europe Genetic Virus Vector Revenue by Application (2016-2021) & (USD Million)

Table 82. Europe Genetic Virus Vector Revenue by Application (2021-2026) & (USD Million)

Table 83. Europe Genetic Virus Vector Revenue by Country (2016-2021) & (USD Million)

Table 84. Europe Genetic Virus Vector Revenue by Country (2021-2026) & (USD Million)

Table 85. Asia-Pacific Genetic Virus Vector Revenue by Type (2016-2021) & (USD Million)

Table 86. Asia-Pacific Genetic Virus Vector Revenue by Type (2021-2026) & (USD Million)

Table 87. Asia-Pacific Genetic Virus Vector Revenue by Application (2016-2021) & (USD Million)

Table 88. Asia-Pacific Genetic Virus Vector Revenue by Application (2021-2026) & (USD Million)

Table 89. Asia-Pacific Genetic Virus Vector Revenue by Region (2016-2021) & (USD Million)

Table 90. Asia-Pacific Genetic Virus Vector Revenue by Region (2021-2026) & (USD Million)

Table 91. South America Genetic Virus Vector Revenue by Type (2016-2021) & (USD Million)

Table 92. South America Genetic Virus Vector Revenue by Type (2021-2026) & (USD Million)

Table 93. South America Genetic Virus Vector Revenue by Application (2016-2021) & (USD Million)

Table 94. South America Genetic Virus Vector Revenue by Application (2021-2026) & (USD Million)

Table 95. South America Genetic Virus Vector Revenue by Country (2016-2021) & (USD Million)

Table 96. South America Genetic Virus Vector Revenue by Country (2021-2026) & (USD Million)

Table 97. Middle East & Africa Genetic Virus Vector Revenue by Type (2016-2021) & (USD Million)

Table 98. Middle East & Africa Genetic Virus Vector Revenue by Type (2021-2026) & (USD Million)

Table 99. Middle East & Africa Genetic Virus Vector Revenue by Application (2016-2021) & (USD Million)

Table 100. Middle East & Africa Genetic Virus Vector Revenue by Application (2021-2026) & (USD Million)

Table 101. Middle East & Africa Genetic Virus Vector Revenue by Country (2016-2021) & (USD Million)

Table 102. Middle East & Africa Genetic Virus Vector Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Genetic Virus Vector Picture

Figure 2. Global Genetic Virus Vector Revenue Market Share by Type in 2020

Figure 3. Retroviral Vectors

Figure 4. Adenoviral Vectors

Figure 5. Adeno-Associated Viral Vectors

Figure 6. Other

Figure 7. Genetic Virus Vector Revenue Market Share by Application in 2020

Figure 8. Gene Therapy Picture

Figure 9. Vaccinology Picture

Figure 10. Global Genetic Virus Vector Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Genetic Virus Vector Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Genetic Virus Vector Revenue Market Share by Region (2016-2026)

Figure 13. Global Genetic Virus Vector Revenue Market Share by Region in 2020

Figure 14. North America Genetic Virus Vector Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Genetic Virus Vector Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Genetic Virus Vector Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Genetic Virus Vector Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Genetic Virus Vector Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Genetic Virus Vector Market Drivers

Figure 20. Genetic Virus Vector Market Restraints

Figure 21. Genetic Virus Vector Market Trends

Figure 22. FUJIFILM Diosynth Biotechnologies U.S.A. Recent Developments and Future Plans

Figure 23. Sanofi Recent Developments and Future Plans

Figure 24. Lonza Recent Developments and Future Plans

Figure 25. Merck KGaA Recent Developments and Future Plans

Figure 26. GENERAL ELECTRIC COMPANY Recent Developments and Future Plans

Figure 27. Oxford BioMedica Recent Developments and Future Plans

Figure 28. Spark Therapeutics, Inc. Recent Developments and Future Plans

Figure 29. uniQure N.V. Recent Developments and Future Plans

Figure 30. FinVector Vision Therapies Recent Developments and Future Plans

Figure 31. Brammer Bio Recent Developments and Future Plans

Figure 32. Cell and Gene Therapy Catapult Recent Developments and Future Plans

Figure 33. Cobra Biologics Recent Developments and Future Plans

Figure 34. REGENXBIO Inc. Recent Developments and Future Plans

Figure 35. Kaneka Eurogentec S.A. Recent Developments and Future Plans

Figure 36. Global Genetic Virus Vector Revenue Share by Players in 2020

Figure 37. Genetic Virus Vector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Genetic Virus Vector Revenue Market Share in 2020

Figure 39. Global Top 10 Players Genetic Virus Vector Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Genetic Virus Vector Revenue Share by Type in 2020

Figure 42. Global Genetic Virus Vector Market Share Forecast by Type (2021-2026)

Figure 43. Global Genetic Virus Vector Revenue Share by Application in 2020

Figure 44. Global Genetic Virus Vector Market Share Forecast by Application (2021-2026)

Figure 45. North America Genetic Virus Vector Sales Market Share by Type (2016-2026)

Figure 46. North America Genetic Virus Vector Sales Market Share by Application (2016-2026)

Figure 47. North America Genetic Virus Vector Revenue Market Share by Country (2016-2026)

Figure 48. United States Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Genetic Virus Vector Sales Market Share by Type (2016-2026)

Figure 52. Europe Genetic Virus Vector Sales Market Share by Application (2016-2026)

Figure 53. Europe Genetic Virus Vector Revenue Market Share by Country (2016-2026)

Figure 54. Germany Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Genetic Virus Vector Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Genetic Virus Vector Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Genetic Virus Vector Revenue Market Share by Region (2016-2026)

Figure 62. China Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Genetic Virus Vector Sales Market Share by Type (2016-2026)

Figure 69. South America Genetic Virus Vector Sales Market Share by Application (2016-2026)

Figure 70. South America Genetic Virus Vector Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Genetic Virus Vector Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Genetic Virus Vector Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Genetic Virus Vector Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Genetic Virus Vector Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz